CReM in the News!

ARRA stimulus grant from the NIH Awarded to CReM: RC2 ‘Grand Opportunities (GO)’ Grant to study iPS Cells

CReM researchers have been awarded an RC2 GO grant to derive differentiated endodermal and hematopoietic lineages from human iPS cells.
The multicenter study, lead by Boston University Principal Investigators, Drs. Darrell Kotton and Gustavo Mostoslavsky, applies reprogramming technology to derive human iPS cells and then characterize their differentiated progeny using bioinformatics approaches.

Millipore Licenses Novel Stem Cell Technology from Boston University

Provides highly efficient method for creating induced pluripotent stem cells

Millipore has licensed the CReM’s STEMCCA single lentiviral vector for reprogramming somatic cells into induced pluripotent stem (iPS) cells. Please click here to read the press release and learn more.

On-line summaries of the latest publications this year from CReM investigators:

coverfig

Cardoso Lab on journal cover

Mouse iPS Cell Colonies

Mouse iPS Cell Colonies

Contact|Directory|BUMC
November 20, 2009
Primary teaching affiliate
of BU School of Medicine